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Evidence has been presented which implicates the complement (C) system as a
potentially important effector of blood coagulation (1) . In studieson rabbit whole
blood, it was found that agents which promoted blood coagulation by the
C-dependent mechanism activated the alternate mechanism of C rather than the
classic pathway (2) . Further, it was found in experiments with human platelets
that zymosan-induced release of serotonin and platelet aggregation were depend-
ent on activation of the C system by the alternate mechanism (3) .
It has been known for some time that activation of C on a cell membrane leads
to production of ultrastructural lesions on the membrane surface (4) . These
lesions are approximately 100 A in diameter surrounded by a white rim 20 A in
thickness . More recently (5) it was shown that activation of the C system by the
alternate mechanism in the presence of red cells led to the appearance of
ultrastructural lesions on the red cell membrane which were morphologically
distinct from those previously described . These lesions were the same shape,
however, they were larger, approximately 150A in diameter and were surrounded
by a white rim 60-80 A in thickness . These lesions were referred to as type II
lesions in order to distinguish them from those previously described (type I) .
The purpose of the present communication is to present evidence indicating
that during blood coagulation, ultrastructural lesions similar to type II were
produced on the platelet membrane . On the other hand, as would be expected,
antibody-dependent activation of the C system on the surface of the platelet by
antibody directed to a membrane-bound antigen led to the production of
ultrastructural lesions of type 1.
Materials and Methods
Platelet Suspensions . Platelet-rich plasma (PRP)' was prepared from sodium citrate (3.2%)
anticoagulated whole blood obtained from normal volunteers . One part anticoagulant was used for
nine parts of blood .PRP was prepared bycentrifugation at 150g for 15 min at 37°C in a Sorvall RC-3
centrifuge (Ivan Sorvall, Inc ., Newtown, Conn .) . The platelet count of the PRP was adjusted to
*This was supported by a grant from the U. S . Public Health Service (HL-14801) .
f Recipient of Faculty Research Award PRA-111 of the American Cancer Society.
' Abbreviation used in thispaper: PRP, platelet-rich plasma .
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200,000/x1 with platelet poor plasma . Washed platelets were prepared using the Ardlie buffer system
as previously described (6) .
Induction of Clot Formation in Platelet Preparations .
￿
Three methods were employed . In the first,
EDTA was added to a preparation ofPRP to a final concentration of0.01 M . Increasing amounts of a
solution of Cal +Mg++ in saline were added to the EDTA-treated PRP over the range from 1/20 of the
EDTA-neutralizing amount to two times the concentration needed to neutralize the chelating effect
of the EDTA . 1 ml of the PRP containing' EDTA and Ca++Mg++ at varying concentrations was
incubated at 37° for 1 h. Electron microscope studies were performed on preparations in which small
clots had formed .
In the second method PRP was centrifuged to remove the platelets . To the platelet-poor plasma
thus obtained, EDTA and Ca++Mg++ were added at concentrations identical to those used in the first
method . 1 ml of the EDTA-containing plasma with varying amounts of Ca++Mg++ was incubated at
37°C for 1 h with 1 ml of a suspension of washed platelets in buffer at a final concentration of
100,000/xl . Ultrastructional analysis was performed on the platelets subsequent to this incubation
procedure and control studies were performed on the initial platelet suspension which had not been
exposed to the EDTA-containing plasma .
In the third method, in order to avoid the use ofEDTA and its possible ultrastructural effect on the
platelet membrane, 1 ml of washed platelets suspended in buffer at 200,000/,ul was incubated at 37°C
for 1 h with 1 ml of a / z dilution of fresh human serum .
Absorption of Serum with Aluminum Hydroxide .
￿
In some experiments, fresh human serum was
absorbed with aluminum hydroxide to remove prothrombin and interfere with thrombin generation
(7) . Initially the absorption of serum with aluminum hydroxide was performed at O°C, room tempera-
ture, and at 37°C . In order to ascertain whether thrombin generation in the serum had been blocked,
0.2 ml of each preparation was incubated at 37°C for 24 h with 0.5 mg fibrinogen. No clot was formed
in the mixture containing fibrinogen and serum absorbed with aluminum hydroxide at room tempera-
ture or at 37° .
C Assays on Serum Absorbed with Aluminum Hydroxide.
￿
The serum which had been absorbed
with aluminum hydroxide at room temperature and at 37°C was tested for its C activity by assays
designed to measure both the activity of the classic mechanism and alternate mechanism of C
activation . Assays were performed to measure whole C and C2 activity by standard hemolytic assays
(8, 9) . Activity of the alternate mechanism was measured by an assay for hemolysis of glutathione-
treated red cells under acid conditions and by inulin-induced lysis of these cells at neutral pH (10-12) .
Further tests for alternate mechanism activity were assays to measure the electrophoretic conversion
of C3 proactivator (C3PA) to the active fragment C3 activator (C3A) and of C3 to its hemolytically
inactive form (C3i) (13) .
It was found that the absorption of serum with aluminum hydroxide at 37°C had removed 40-60%
of the C activity . However, in the serum absorbed at room temperature, no decrease in C level was
demonstrable by any of the tests employed . Since serum treated in this manner did not clot when
incubated with fibrinogen, this reagent was employed as the source of thrombin-free-C containing
serum throughout the present study .
Incubation of Platelets with Thrombin .
￿
1 ml of washed platelets (230,000/xl) in buffer was
incubated at 37°C for 60 min with 1, 0 .1, or 0.01 U of purified human thrombin, kindly supplied by Dr .
Peter Harpel, New York Hospital-Cornell Medical Center, New York, (100 U/ml of sterile saline)
either alone or subsequent to the addition of 0 .5 ml of fresh human serum as a source of C .
Preparation of C3-DepletedHuman Serum .
￿
The -y-globulin fraction was prepared from a rabbit
serum containing monospecific antibody to human C3 by ammonium sulfate (50%) precipitation
followed by TEAE-cellulose chromatography utilizing phosphate buffer at pH 5.0, 0.0175 M . This
preparation was conjugated to sepharose 4B by the method of Cuatrecasas (14) . 1 ml of the
anti-C3-conjugated Sepharose was mixed with 1 ml of fresh human serum and allowed to stand at
0°C for 1 h . After centrifugation, the absorbed serum was tested for its content of C3 . It was found
that approximately 80% of the original C3 contained in the serum had been removed by this
procedure .
Platelet-Antiplatelet Interaction .
￿
The serum containing antiplatelet antibody was obtained from
a woman who had been isoimmunized to one or more antigenic determinants on her husband's
platelets . In addition to reacting with her husband's platelets, the antibody was found to react with
platelets from all of six individuals tested (M . J . Polley, unpublished observations) . No attempts wereMARGARET J . POLLEY AND RALPH L . NACHMAN
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made to determine the antigenic specificity of this antibody . 0.5 ml of serum containing the platelet
antibody and 0.5 ml fresh human serum as asource of C were incubated at 37°C for 60 min with 0.5
ml of the washed platelet preparation .
Preparation of Platelets for Electron Microscopy .
￿
Platelets from each method of treatmentwere
washed once with normal saline and then three times with a 1/10 dilution of saline buffered topH 6.5.
After the first wash in diluted saline, the platelet suspension was frozen at -70°C for 15 min before
the washing steps were continued .
The platelet stroma was stained with 2% sodium silicotungstate and applied to grids coated with
collodion and carbon . The grids were viewed with a Philips 301 electron microscope (Philips
Electronic Instruments, Mount Vernon, N. Y.) at 80 kv .
Results
C-Induced Morphologic Changes in Platelets during Coagulation . When
washed platelets which had not been incubated in vitro with plasma or serum
were viewed under the electron microscope, no ultrastructural lesions were seen .
Similarly, lesions were not seen in platelets after exposure to nonrecalcified
EDTA plasma . However, asshown in Fig . 1, ultrastructural lesions were found on
the platelet membrane subsequent to incubation with EDTA plasma to which
Ca++ had been added in an amount sufficient to neutralize the chelating activity
of the EDTA resulting in clot formation . These lesions were few in number and
were the same shape and size as those produced in red cells by activation of C by
the alternate mechanism (type II) (5) . The lesions were 150 A in diameter across
the dark central areas surrounded by a white rim approximately 60 A in thickness
(Fig . 1 b) . Occasionally a lesion was seen in which the rim was not at a constant
thickness all around the lesion but appeared to be much thickened in one area .
An example of a lesion of this type is shown in Fig . 1 c.
When washed platelets were incubated with fresh untreated serum, lesions
morphologically similar to those produced by the recalcified plasma were
produced on the platelet membrane . That these lesions were thrombin depend-
ent was demonstrated in an experiment in which thrombin generation was
prevented by absorption of the serum with aluminum hydroxide . When platelets
were incubated for 1 h at 37°C with the "thrombin-free" serum and then
processed for electron microscopy in the usual way, no ultrastructural lesions
were seen (Table I) .
In order to ascertain whether thrombin alone would induce morphologic
changes in the platelet membrane, washed platelets were incubated in buffer
with purified human thrombin and then viewed ultrastructurally . Platelets which
had beelz treated with thrombin alone were morphologically indistinguishable
from those that had had no such treatment . However, as was expected, ultra-
structural lesions were visible in those platelets which had been incubated with
thrombin together with C (provided asaluminum hydroxide absorbed serum) .
When platelets were incubated with serum which contained thrombin but was
80% depleted in its C3 content, the number of ultrastructural lesions visualized
were much fewer than when serum containing a normal amount of C3 was
employed . In fact, it was found necessary to view several areas of platelet
membranes in order to observe a single lesion when the serum used forincubation
of the plateletshad been largely C3 depleted . As shown in Table I onlytwo type II
lesions were visualized in 10 areas of platelet membrane, each 0.45,umz .1264
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FIG . 1 .
￿
Platelet membrane subsequent to incubation with EDTA-containing plasma to which
Ca- andMg" hadbeen added (see text) . (a) x 102,000 . Solid bar represents 1,000 A. Arrows
indicate ultrastructural lesions. (b and c) Selected areas ofa x 336,000. Solid bars represent 500
A.MARGARET J . POLLEY AND RALPH L. NACHMAN
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TABLE I
Quantitation of Ultrastructural Lesions in Membranes of Platelets*
Incubated with Various Reagents
Reagent No. oftype 11$
ultrastructurallesions
* Platelets utilized were a preparation of "washed platelets." For details of this
preparation and of all other reagents listed in this table, see Materials and
Methods section.
$ Thenumber of ultrastructural lesions visualized in 10 arbitrarily selected areas
of platelet membrane, each approximately 0.45 jm2.
C-Induced Ultrastructural Changes in Platelets Sensitized with
Antibody. As shown in Fig. 2, ultrastructural lesions of identical morphology to
type I seen in red cells were demonstrated on platelets subsequent to their
interaction with antiplatelet antibody and C. Since the source of both antibody
and C was serum, in addition to type I lesions, some type II lesions were also seen .
As is seen in red cells (5) the number of type I lesions was far greater than the
number of type II lesions .
Morphological Comparison of Type I and Type II Ultrastructural Lesions seen
in Platelets. Fig. 3 demonstrates both visually and graphically the comparative
size of type I and type II lesions. Type I lesions were approximately 100 A in
diameter surrounded by a rim 20 A in width which are similar in size to those
lesions produced in red cells by immune lysis (4) . In comparison, type. II lesions
were approximately 150 A in diameter surrounded by a rim 60 A in width which
are identical in dimension to lesions produced in red cells by activation of the
alternate mechanism (5) . Table II lists the mean of multiple measurements of
both types of lesions and the calculated standard deviations .
Discussion
Most studies of the effect of C on membranes have been performed with red cells .
Some years ago (4) it was shown that activation of C produced distinct
ultrastructural changes on the membrane surface. More recently (5) it has been
shown that the morphology of these ultrastructural changes varies depending on
whether C is activated by the classic or by the alternate mechanism.
To date, C-induced ultrastructural changes in the platelet membrane have not
been described. In our present studies we have found that during blood
coagulation ultrastructural changes appeared on the surface of the platelet.
EDTA-containingplasma 0
EDTA-containing plasma + Ca*+ Mg*' 21
Serum 17
Thrombin-depleted serum 0
C3-depleted serum 2
Thrombin 0
Thrombin + C 271266
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FIG. 2 .
￿
Platelet membrane subsequent to incubation with antiplatelet antibody and C. x
336,000 . Solid bar represents 500A. Arrows indicate representative lesions.
FIG. 3. Visual and graphic comparison of type I and type II lesions . Areas selected from
electron micrographs both x 336,000 .
These changes were found to be dependent on the presence of both thrombin and
C3 . The changes seen electron microscopically in the platelet membrane were
morphologically identical to those seen and described as type II lesions which are
produced in red cells by the activation of C by the alternate mechanism .
On the other hand, when antibody-mediated activation of C occurs with
platelets, ultrastructural changes take place on the membrane surface and
lesions are produced which are identical in morphology to the type I lesions
produced in red cells by activation of C by the classic mechanism .
These studies raise the intriguing possibility that thrombin-platelet inter-MARGARET J . POLLEY AND RALPH L. NACHMAN
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TABLE II
Dimensions of Two Morphologically different Ultrastructural Lesions
Visualized in Platelet Membranes
Type of
ultrastructural
lesion
Total
￿
Diameter of
￿
Thickness of
diameter
￿
dark central area
￿
white rim
Á
￿
A
￿
Á
Type 1*
￿
139 (13)$
￿
96(9)
￿
23(9)
Type II§
￿
270(21)
￿
149(12)
￿
58(10)
* Lesions seen in platelets treated with antiplatelet antibody and C (for details see
text) .
$ Figure represents mean of at least 20 measurements of lesions in electron
micrographs at five different magnifications . The figure in parenthesis is the
calculated standard deviation .
§ Lesions seen in platelets incubated with recalcified plasma (for details see text) .
actions are mediated at least in part by the activation of the alternative C path-
way,
Summary
During blood coagulation ultrastructural lesions were produced on the platelet
membrane . They were dependent on the presence of both thrombin and
complement (C) and were morphologically identical to the C-dependent ultra-
structural lesions (type II) seen in red cells subsequent to activation of C by the
alternate mechanism . Though similar in shape they differed in size from
ultrastructural lesions (type I) produced by activation of C via the classic
mechanism . Lesions of type I were seen on the platelet surface subsequent to
antibody-dependent activation of the C system .
The authors gratefully acknowledge the skillful technical assistance of Miss Bonnye Pillar and Mrs .
Linda Metakis .
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